These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 30721582)

  • 1. Molecular Epidemiological Study on Passive Smoking and Estrogen Receptor Expression in Never-smokers with Non-small Cell Lung Cancer.
    Naoki Y; Kawaguchi T; Isa SI; Shimizu S; Tamiya A; Asai K; Kudoh S; Hirata K
    Osaka City Med J; 2016 Dec; 62(2):77-84. PubMed ID: 30721582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
    Soo RA; Kubo A; Ando M; Kawaguchi T; Ahn MJ; Ou SI
    Clin Lung Cancer; 2017 Sep; 18(5):535-542. PubMed ID: 28433570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long exposure of environmental tobacco smoke associated with activating EGFR mutations in never-smokers with non-small cell lung cancer.
    Kawaguchi T; Ando M; Kubo A; Takada M; Atagi S; Okishio K; Asami K; Matsumura A; Tsujino K; Ignatius OS; Sasaki H
    Clin Cancer Res; 2011 Jan; 17(1):39-45. PubMed ID: 21059816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificities of lung adenocarcinoma in women who have never smoked.
    Mazières J; Rouquette I; Lepage B; Milia J; Brouchet L; Guibert N; Beau-Faller M; Validire P; Hofman P; Fouret P
    J Thorac Oncol; 2013 Jul; 8(7):923-9. PubMed ID: 23608817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features.
    Yano T; Haro A; Shikada Y; Maruyama R; Maehara Y
    Int J Clin Oncol; 2011 Aug; 16(4):287-93. PubMed ID: 21562939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.
    Raso MG; Behrens C; Herynk MH; Liu S; Prudkin L; Ozburn NC; Woods DM; Tang X; Mehran RJ; Moran C; Lee JJ; Wistuba II
    Clin Cancer Res; 2009 Sep; 15(17):5359-68. PubMed ID: 19706809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.
    Lee YJ; Cho BC; Jee SH; Moon JW; Kim SK; Chang J; Chung KY; Park IK; Choi SH; Kim JH
    J Clin Oncol; 2010 Jan; 28(3):487-92. PubMed ID: 20008630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07.
    Viñolas N; Garrido P; Isla D; Provencio M; Majem M; Artal A; Carcereny E; Garcia Campelo R; Lianes P; De La Peñas R; Felip E
    Cancer Invest; 2017 May; 35(5):358-365. PubMed ID: 28350480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424).
    Cheng TD; Darke AK; Redman MW; Zirpoli GR; Davis W; Payne Ondracek R; Bshara W; Omilian AR; Kratzke R; Reid ME; Molina JR; Kolesar JM; Chen Y; MacRae RM; Moon J; Mack P; Gandara DR; Kelly K; Santella RM; Albain KS; Ambrosone CB
    J Natl Cancer Inst; 2018 Jul; 110(7):734-742. PubMed ID: 29346580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent epidermal growth factor receptor mutation patterns between smokers and non-smokers with lung adenocarcinoma.
    Tseng JS; Wang CL; Yang TY; Chen CY; Yang CT; Chen KC; Hsu KH; Tsai CR; Chang GC
    Lung Cancer; 2015 Dec; 90(3):472-6. PubMed ID: 26474957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple primary malignancies in patients with non-small cell lung cancer.
    Fujita S; Masago K; Takeshita J; Togashi Y; Hata A; Kaji R; Kokubo M; Katakami N
    Intern Med; 2015; 54(3):325-31. PubMed ID: 25748742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?
    Ou SH
    J Clin Pathol; 2013 Oct; 66(10):839-46. PubMed ID: 23661716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptor and growth factor receptor expression in human nonsmall cell lung cancers using cells procured by laser-capture microdissection.
    Kerr A; Eliason JF; Wittliff JL
    Adv Exp Med Biol; 2008; 617():377-84. PubMed ID: 18497061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proportion and clinical features of never-smokers with non-small cell lung cancer.
    Cho J; Choi SM; Lee J; Lee CH; Lee SM; Kim DW; Yim JJ; Kim YT; Yoo CG; Kim YW; Han SK; Park YS
    Chin J Cancer; 2017 Feb; 36(1):20. PubMed ID: 28179026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between hormone receptor expression and epidermal growth factor receptor mutation in patients operated on for non-small cell lung cancer.
    Sun HB; Zheng Y; Ou W; Fang Q; Li P; Ye X; Zhang BB; Yang H; Wang SY
    Ann Thorac Surg; 2011 May; 91(5):1562-7. PubMed ID: 21524465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genomic landscape of nonsmall cell lung carcinoma in never smokers.
    Boeckx B; Shahi RB; Smeets D; De Brakeleer S; Decoster L; Van Brussel T; Galdermans D; Vercauter P; Decoster L; Alexander P; Berchem G; Ocak S; Vuylsteke P; Deschepper K; Lambrechts M; Cappoen N; Teugels E; Lambrechts D; De Greve J
    Int J Cancer; 2020 Jun; 146(11):3207-3218. PubMed ID: 31745979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
    Kim HR; Shim HS; Chung JH; Lee YJ; Hong YK; Rha SY; Kim SH; Ha SJ; Kim SK; Chung KY; Soo R; Kim JH; Cho BC
    Cancer; 2012 Feb; 118(3):729-39. PubMed ID: 21720997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer.
    Kawai H; Ishii A; Washiya K; Konno T; Kon H; Yamaya C; Ono I; Minamiya Y; Ogawa J
    Clin Cancer Res; 2005 Jul; 11(14):5084-9. PubMed ID: 16033821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
    Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH
    Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of estrogen receptor beta predicts a clinical response and longer progression-free survival after treatment with EGFR-TKI for adenocarcinoma of the lung.
    Nose N; Uramoto H; Iwata T; Hanagiri T; Yasumoto K
    Lung Cancer; 2011 Mar; 71(3):350-5. PubMed ID: 20615575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.